Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Drijfhout

Showing results (51-60 of 100) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifsA Geluk, K E van Meijgaarden, S Southwood, et al.
Annals of the New York Academy of Sciences|May 22, 2002
Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virusB O Roep, H S Hiemstra, N C Schloot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteinsW M Kast, R M Brandt, J Sidney, et al.
European Journal of Immunology|December 1, 1994
Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide libraryG A Schellekens, E Lasonder, M Feijlbrief, et al.
International Journal of Cancer|January 27, 1997
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitopeA B Bakker, S H van der Burg, R J Huijbens, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitopeM P Vierboom, M C Feltkamp, A Neisig, et al.
Archives of Virology|January 1, 1988
Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coliC H Kocken, H J Geerligs, C A Bos, et al.
Diabetes|June 27, 2000
T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetesC J Hawkes, N C Schloot, J Marks, et al.
The Journal of General Virology|August 1, 1990
Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from miceH J Geerligs, C H Kocken, J W Drijfhout, et al.
European Journal of Immunology|October 30, 1999
Glutenin is involved in the gluten-driven mucosal T cell responseY van de Wal, Y M Kooy, P van Veelen, et al.
Pageof 10

Showing results (51-60 of 100) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1994
HLA-DR3 molecules can bind peptides carrying two alternative specific submotifsA Geluk, K E van Meijgaarden, S Southwood, et al.
Annals of the New York Academy of Sciences|May 22, 2002
Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virusB O Roep, H S Hiemstra, N C Schloot, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1994
Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteinsW M Kast, R M Brandt, J Sidney, et al.
European Journal of Immunology|December 1, 1994
Identification of the core residues of the epitope of a monoclonal antibody raised against glycoprotein D of herpes simplex virus type 1 by screening of a random peptide libraryG A Schellekens, E Lasonder, M Feijlbrief, et al.
International Journal of Cancer|January 27, 1997
Analogues of CTL epitopes with improved MHC class-I binding capacity elicit anti-melanoma CTL recognizing the wild-type epitopeA B Bakker, S H van der Burg, R J Huijbens, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 1998
Peptide vaccination with an anchor-replaced CTL epitope protects against human papillomavirus type 16-induced tumors expressing the wild-type epitopeM P Vierboom, M C Feltkamp, A Neisig, et al.
Archives of Virology|January 1, 1988
Immunological properties of an N-terminal fragment of herpes simplex virus type 1 glycoprotein D expressed in Escherichia coliC H Kocken, H J Geerligs, C A Bos, et al.
Diabetes|June 27, 2000
T-cell lines reactive to an immunodominant epitope of the tyrosine phosphatase-like autoantigen IA-2 in type 1 diabetesC J Hawkes, N C Schloot, J Marks, et al.
The Journal of General Virology|August 1, 1990
Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from miceH J Geerligs, C H Kocken, J W Drijfhout, et al.
European Journal of Immunology|October 30, 1999
Glutenin is involved in the gluten-driven mucosal T cell responseY van de Wal, Y M Kooy, P van Veelen, et al.
Pageof 10